NCT05544643View on ClinicalTrials.gov

Safety and Efficacy of Medtronic Extended Mio 30 Infusion Set

NACompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

August 4, 2022

Primary Completion Date

August 4, 2022

Study Completion Date

August 4, 2022

Conditions

Diabetes Mellitus, Type 1

Interventions

DEVICE

Medtronic Extended Mio 30 Infusion Set

Safety and Efficacy of Medtronic Extended Mio 30 Infusion Set

Trial Locations (2)

52662

Sheba Medical Center, Ramat Gan

Unknown

Sheba Medical Center, Tel Litwinsky

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Medtronic

INDUSTRY

lead

Sheba Medical Center

OTHER_GOV

NCT05544643 - Safety and Efficacy of Medtronic Extended Mio 30 Infusion Set | Biotech Hunter | Biotech Hunter